Manhattan Stitching Company sold KN95 and other face masks with COVID-19 claims without FDA approval or clearance.
What happened
FDA reviewed the company’s websites and social media pages on February 11, 2021. It found the company offering KN95 Face Mask, 3-ply Face Mask, and 3-Ply Disposable Youth Face Mask with statements indicating use for COVID-19, without FDA marketing approval, clearance, or authorization. FDA also found a “Certificate of Registration” displayed with the KN95 mask that used the FDA logo and implied FDA approval or endorsement.
What FDA found
FDA says the company offered KN95 and other face masks for COVID-19 use without FDA marketing approval, clearance, or authorization, making them adulterated.
section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B)FDA says the company did not give the required premarket notification (510(k)) before introducing the devices into commercial distribution, making them misbranded.
section 502(o), 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)FDA says the KN95 mask labeling was false or misleading because a “Certificate of Registration” with the FDA logo implied FDA approval or endorsement.
section 502(a), 21 U.S.C. § 352(a); 21 CFR 807.39
What FDA wants
FDA asks the company to immediately stop selling any adulterated or misbranded products for COVID-19 and to reply in writing within 15 business days with the steps taken, supporting documents, and a plan to prevent repeat violations.
Who should pay attention
- online sellers and retailers of imported face masks
- brands relying on supplier FDA registration certificates
- distributors of KN95 and disposable masks
This is a summary. Read the original letter on fda.gov.